Bluebird partners with Bay Area biotech on new cancer drug targets
August 23, 2018 at 12:22 PM EDT
The firms said the $30 million deal could produce treatments for cancer patients who are currently without options.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.